[Federal Register Volume 67, Number 148 (Thursday, August 1, 2002)]
[Notices]
[Pages 49945-49946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19374]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Dental Products Panel of the Medical Devices Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Dental Products Panel of the Medical Devices 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on August 22, 2002, from 8 
a.m. to 6 p.m.
    Location: Holiday Inn, Walker/Whetstone Rooms, Two Montgomery 
Village Ave., Gaithersburg, MD.
    Contact Person: Pamela D. Scott, Center for Devices and 
Radiological Health (HFZ-480), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-827-5283, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12518. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will discuss, make recommendations, and vote 
on a premarket approval application for a total temporomandibular joint 
prosthesis for reconstruction of the temporomandibular joint.
    Background information, including the agenda and questions for the 
committee, will be available to the public one business day before the 
meeting, on the Internet at http://www.fda.gov/cdrh/panelmtg.html. 
Material for the August 22, 2002, meeting will be posted on August 21, 
2002.
    Procedure: On August 22, 2002, from 8 a.m. to 5 p.m., the meeting 
is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
August 5, 2002. Oral presentations from the public will be scheduled 
between approximately 8:15 a.m. and 8:45 a.m. Near the end of the 
committee deliberations, a 30-minute open public session will be 
conducted for interested persons to address issues specific to the 
submission before the committee. Time allotted for each presentation 
may be limited. Those desiring to make formal oral presentations should 
notify the contact person before August 19, 2002, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Closed Committee Deliberations: On August 22, 2002, from 5 p.m. to 
6 p.m., the meeting will be closed to permit FDA staff to present to 
the committee trade secret and/or confidential commercial information 
regarding dental device issues. This portion of the meeting will be 
closed to permit discussion of this information (5 U.S.C. 552b(c)(4)).
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact AnnMarie Williams, 
Conference Management Staff, at 301-594-1283, ext. 113, at least 7 days 
in advance of the meeting.

[[Page 49946]]

    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: July 25, 2002.
Linda Arey Skladany,
Senior Associate Commissioner for External Relations.
[FR Doc. 02-19374 Filed 7-31-02; 8:45 am]
BILLING CODE 4160-01-S